| |
| |
|
| Insider
Information: |
Spear Matthew A. |
| Relationship: |
Chief Medical Officer |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
111,485 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$319,962 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
111,485 |
|
|
| Total
Value |
$319,962 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Poseida Therapeutics, Inc. |
PSTX |
Chief Medical Officer |
2022-03-01 |
111,485 |
2021-01-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PSTX |
Poseida Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
111,485 |
0 |
- |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2021-12-06 |
4 |
OE |
$1.32 |
$13,220 |
D/D |
10,000 |
61,485 |
0 |
- |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2021-09-09 |
4 |
OE |
$1.32 |
$13,220 |
D/D |
10,000 |
51,485 |
0 |
- |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2021-08-20 |
4 |
AS |
$8.79 |
$35,142 |
D/D |
(4,000) |
41,485 |
0 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2021-08-20 |
4 |
OE |
$1.32 |
$5,288 |
D/D |
4,000 |
45,485 |
0 |
- |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2021-07-28 |
4 |
OE |
$1.32 |
$26,440 |
D/D |
20,000 |
41,485 |
0 |
- |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2021-06-17 |
4 |
OE |
$1.32 |
$6,610 |
D/D |
5,000 |
21,485 |
0 |
- |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2021-06-11 |
4 |
AS |
$9.44 |
$37,747 |
D/D |
(4,000) |
16,485 |
0 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2021-06-11 |
4 |
OE |
$1.32 |
$5,288 |
D/D |
4,000 |
20,485 |
0 |
- |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2021-04-23 |
4 |
OE |
$1.32 |
$6,610 |
D/D |
5,000 |
16,485 |
0 |
- |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2021-04-21 |
4 |
AS |
$8.44 |
$33,752 |
D/D |
(4,000) |
11,485 |
0 |
% |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2021-04-21 |
4 |
OE |
$1.32 |
$5,288 |
D/D |
4,000 |
15,485 |
0 |
- |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2021-01-15 |
4 |
OE |
$1.32 |
$10,000 |
D/D |
7,564 |
11,485 |
0 |
- |
|
| PSTX |
Poseida Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2021-01-08 |
4 |
OE |
$1.32 |
$5,184 |
D/D |
3,921 |
3,921 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
